Target intelligence / Profile preview

Zinc-finger and other zinc-structural protein domains (ZnF) (ZnF)

Target
ZnF
Molecular classification
Transcription factor, Enzyme, Structural motif, Protein-binding domain
01

Overview

Zinc-finger and other zinc-structural protein domains are ubiquitous structural motifs characterized by the coordination of one or more zinc ions by cysteine and histidine residues, which stabilizes the protein's functional fold (Klug, 2010). These domains are found in approximately 3% of the human genome and are critical for diverse biological processes, including DNA recognition, RNA binding, and protein-protein interactions (Cassandrier et al., 2021). In a therapeutic context, these motifs are often targeted in viral proteins, such as the HIV-1 nucleocapsid protein, and in oncogenic transcription factors where they mediate DNA binding (Rice et al., 1995). Drugs targeting these domains, known as zinc ejectors, typically function by oxidizing or covalently modifying the coordinating sulfur atoms of cysteine residues, leading to the release of the zinc ion and subsequent loss of the protein's three-dimensional structure and function (Pace & Weerapana, 2014). While promising, targeting these domains presents significant challenges due to the high risk of off-target effects across the vast number of zinc-finger-containing proteins in the human body (Wuthrich, 2000). Consequently, current research focuses on developing site-specific ejectors or targeting unique pockets adjacent to the zinc-binding site to improve selectivity (Maret, 2013).

Other names
Zinc finger motifZinc-binding domainZn-fingerZinc-coordinated domain
02

Mechanism of action

Zinc ejection through the chemical modification (oxidation or alkylation) of zinc-coordinating cysteine residues, resulting in the collapse of the domain's tertiary structure and loss of biological activity (Rice et al., 1995; Pace & Weerapana, 2014).

03

Biological functions

DNA bindingRNA bindingProtein-protein interactionTranscriptional regulationUbiquitination
04

Disease associations

CancerInfectionNeurodegenerative diseaseGenetic disorder
05

Safety considerations

Off-target effectsSystemic toxicityLack of selectivityMetal dyshomeostasisCross-reactivity with essential zinc-finger proteins
06

Interacting drugs

Azodicarbonamide

5 more in the full profile.

07

Biomarkers

Protein expression levelsZinc ejection assaysmRNA levels of specific ZnF-containing genesZinc ion release

Beyond the preview

Go deeper on Zinc-finger and other zinc-structural protein domains (ZnF) (ZnF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc-finger and other zinc-structural protein domains (ZnF) (ZnF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call